Close Menu

NEW YORK (GenomeWeb) – NanoString Technologies said today that it has entered new commercial partnerships with five contract research organizations aimed at expanding access to its Digital Spatial Profiling (DSP) technology.

The agreements — with Covance, Cancer Genetics, Core Diagnostics, Propath UK, and another undisclosed company — will allow the CROS to market DSP services to their customers through a technology access program in advance of NanoString's expected commercial launch of the DSP instrument platform in 2019.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.

Jun
18
Sponsored by
ArcherDX

This webinar will discuss background and clinical genomics of NTRK fusion detection in cancer. NTRK fusions are the focus of new therapeutic options, but clonal and subclonal lesions are notoriously difficult to detect.